RG

Ramadasu Guruvindapalli

Active Director Director DIN 11486875
DIN 11486875 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramadasu Guruvindapalli

Data last updated:

Ramadasu Guruvindapalli is a Director at Pevexa Lifesciences Private Limited (since 2026). The company operates in Pharma.

DIN 11486875
Primary Designation Director
Industry Pharma
First Appointment 16 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pevexa Lifesciences Private Limited U21001TN2026PTC188515
Director16 Jan 20262026Active

Board colleagues of Ramadasu Guruvindapalli

NameDINCompanyDesignation
Bommattula Venkat Rao11486874Pevexa Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pevexa Lifesciences Private Limited
Premium access

Shareholding and investment profile for Ramadasu Guruvindapalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramadasu Guruvindapalli

Ramadasu Guruvindapalli currently holds 1 directorship: Pevexa Lifesciences Private Limited (Director, since 16 Jan 2026).

Ramadasu Guruvindapalli was first appointed on 16 Jan 2026 as Director at Pevexa Lifesciences Private Limited.

The current boards of Ramadasu Guruvindapalli's companies include Bommattula Venkat Rao (Pevexa Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available